Jiesi Luo

School of Basic Medical Sciences

H指数:18

被引数:1,348

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Development and internal validation of an interpretable machine learning model using routine laboratory data for systemic sclerosis-associated pulmonary arterial hypertension

基于常规实验室数据开发并内部验证用于系统性硬化症相关肺动脉高压的可解释机器学习模型

Rheumatology International

IF2.9

2026-07-160

PRE

Prediction of cyclin-dependent proteins using pre-trained protein language models and effective neural network architectures

利用预训练蛋白质语言模型和有效的神经网络架构预测细胞周期蛋白依赖性蛋白

Analytical Biochemistry

IF2.5

2026-03-210

PRE

A quantitative approach to modeling transcription factor binding specificity from DNA sequences

基于DNA序列的转录因子结合特异性建模的定量方法

Array

IF4.5

2025-11-250

OAAI

Ginkgolic acid: a novel IL1R1 agonist facilitating megakaryocyte differentiation and platelet production via the SRC/MEK/ERK pathway

银杏酚酸：一种新型的IL1R1激动剂，可通过SRC/MEK/ERK通路促进巨核细胞分化和血小板生成。

International Immunopharmacology

IF4.7

2025-11-210

PRE

Original Multimodal discovery of bavachinin A: A natural FLT3 agonist for treating thrombocytopenia

多模态发现巴娃西尼A：一种治疗血小板减少症的天然FLT3激动剂

PHYTOMEDICINE

IF8.3

2025-05-010

PRE

Capsule neural network and its applications in drug discovery

胶囊神经网络及其在药物发现中的应用

ISCIENCE

IF4.1

2025-04-010

OAAI

Oxymatrine, a novel TLR2 agonist, promotes megakaryopoiesis and thrombopoiesis through the STING/NF-KB pathway

JOURNAL OF PHARMACEUTICAL ANALYSIS

IF8.9

2025-01-010

OAAI

Machine learning to guide the use of plasma technology for antibiotic degradation

JOURNAL OF HAZARDOUS MATERIALS

IF11.3

2024-12-010

PRE

Development and validation of a predictive model for end-stage renal disease in systemic lupus erythematosus patients

RHEUMATOLOGY INTERNATIONAL

IF2.9

2024-08-210

PRE

Identification of Active Molecules against Thrombocytopenia through Machine Learning

JOURNAL OF CHEMICAL INFORMATION AND MODELING

IF5.3

2024-08-070

PRE

Alnustone promotes megakaryocyte differentiation and platelet production via the interleukin-17A/interleukin-17A receptor/Src/RAC1/MEK/ERK signaling pathway

EUROPEAN JOURNAL OF PHARMACOLOGY

IF4.7

2024-05-011

PRE

Activating SRC/MAPK signaling via 5-HT1A receptor contributes to the effect of vilazodone on improving thrombocytopenia

ELIFE

IF0

2024-04-040

Interleukins in Platelet Biology: Unraveling the Complex Regulatory Network

PHARMACEUTICALS

IF4.8

2024-01-134

OAAI

Identification of thrombopoiesis inducer based on a hybrid deep neural network model

THROMBOSIS RESEARCH

IF3.4

2023-06-013

PRE

Fast and Efficient Design of Deep Neural Networks for Predicting N7-Methylguanosine Sites Using autoBioSeqpy

ACS OMEGA

IF4.3

2023-05-232

OAAI

The combination of machine learning and transcriptomics reveals a novel megakaryopoiesis inducer, MO-A, that promotes thrombopoiesis by activating FGF1/FGFR1/PI3K/Akt/NF-?B signaling

EUROPEAN JOURNAL OF PHARMACOLOGY

IF4.7

2023-04-014

PRE

Targeting a thrombopoietin-independent strategy in the discovery of a novel inducer of megakaryocytopoiesis, DMAG, for the treatment of thrombocytopenia

HAEMATOLOGICA

IF7.9

2022-12-229

OAAI

The applications of deep learning algorithms on in silico druggable proteins identification

深度学习算法在计算机药物蛋白质鉴定中的应用

JOURNAL OF ADVANCED RESEARCH

IF13

2022-11-0117

OAAI

Multi-model predictive analysis of RNA solvent accessibility based on modified residual attention mechanism

基于改进剩余注意机制的RNA溶剂可及性多模型预测分析

BRIEFINGS IN BIOINFORMATICS

IF7.7

2022-10-271

PRE

Systematic Analysis and Accurate Identification of DNA N4-Methylcytosine Sites by Deep Learning

FRONTIERS IN MICROBIOLOGY

IF4.5

2022-03-1510

OAAI

Jiesi Luo

个人简介

教育背景

工作经历

荣誉奖项

研究方向